Casdin Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7
- Investments
-
272
- Portfolio
-
71
- Exits
-
128
Casdin Capital General Information
Company Description
Founded in 2012, Casdin Capital is a venture capital firm based in New York. The firm seeks to invest in the life sciences, oncology, digital health, agtech, and healthcare sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.casdincapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1350 Avenue of the Americas
- Suite 2600
- New York, NY 10019
- United States
Casdin Capital Investments (272)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Atrium Therapeutics | 12-Nov-2026 | PIPE | Biotechnology | Generating Revenue | ||
| Z-Alpha Therapeutics | 12-Nov-2026 | Drug Discovery | Generating Revenue | |||
| Multiply Labs | 02-Nov-2026 | Other Hardware | Generating Revenue | |||
| Prana Therapies | 26-Oct-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Flare Therapeutics | 30-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Serapha Bio | 22-Jun-2026 | Discovery Tools (Healthcare) | Generating Revenue | |||
| City Therapeutics | 04-Jun-2026 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Adlai Nortye | 16-Apr-2026 | Drug Discovery | Generating Revenue | |||
| Adlai Nortye | 02-Feb-2026 | PIPE | Drug Discovery | Generating Revenue | ||
| Apella (Other Healthcare Technology Systems) | 08-Jan-2026 | Later Stage VC | Enterprise Systems (Healthcare) | Generating Revenue |
Casdin Capital Exits (128)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| City Therapeutics | 15-Oct-2026 | IPO | |
| Biolife Solutions | 06-Oct-2026 | ||
| Genomatica | 12-Aug-2026 | ||
| NanoCellect Biomedical | 24-Jul-2026 | ||
| Neurogene | 02-Jul-2026 | ||
| Parabilis Medicines | 10-Jun-2026 | ||
| Relay Therapeutics | 22-May-2026 | ||
| iVexSol | 22-Apr-2026 | ||
| Loop Medical | 18-Mar-2026 | Bankruptcy: Liquidation | |
| TMRW Life Sciences | 04-Feb-2026 | Buyout/LBO |
Casdin Capital Investments by Industry, Year, and Region
Casdin Capital Co-Investors (348)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GV | 15 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| ARCH Venture Partners |
|
|
|||
| Andreessen Horowitz |
|
|
|||
| S32 |
|
|
Casdin Capital FAQs
-
What is Casdin Capital?
Founded in 2012, Casdin Capital is a venture capital firm based in New York.
-
When was Casdin Capital founded?
Casdin Capital was founded in 2012.
-
Where is Casdin Capital headquartered?
Casdin Capital is headquartered in New York, NY.
-
What is Casdin Capital's total asset value?
Casdin Capital has around in total assets under management.
-
How many investments has Casdin Capital made?
Casdin Capital has made 272 investments.
-
What has Casdin Capital invested in?
Casdin Capital has made numerous investments in companies like Atrium Therapeutics, Z-Alpha Therapeutics, and Multiply Labs within the Biotechnology, Drug Discovery, and Hardware industries.
-
What has Casdin Capital invested in recently?
Casdin Capital's latest investment was on 12-Nov-2026 in Atrium Therapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process